Rejected after review — what to do next

A rejection after review comes with something a desk rejection does not: several hours of expert attention on your manuscript. The reviews are worth more than the decision, and the first task is not choosing a journal but sorting what you were told. Sorting takes an afternoon and decides the rest: whether you revise, where you send it, and what you say.

Give it a week. Rejections are read badly on the day they arrive. The two errors of the first forty-eight hours — resubmitting unchanged to the next journal down, and writing an appeal that contests a judgement rather than a fact — are both made from the decision letter instead of from the reviews, and the second is covered elsewhere in this family: see when to appeal a rejection for the test that separates the appeal that can work from the one that cannot.

Sort every comment into three piles

Sorting a review set means assigning every numbered comment to one of three piles — recurs anywhere, venue-specific, or wrong — before you make any decision about journals. Do it in a document, comment by comment, keeping the reviewers’ own numbering, because that document becomes the revision list and, if the paper is revised rather than moved, the skeleton of a response to reviewers.

Will recur anywhere. Objections about design, analysis, or claims exceeding evidence. Reviewers at other journals are drawn from the same community and will notice the same things. These must be addressed before the paper goes anywhere, and addressing them is the entire argument against resubmitting immediately.

Venue-specific. Significance thresholds, scope, expectations about mechanism, clinical relevance requirements. These may simply not apply at a different journal. Note them and move on.

Wrong. Some comments are mistaken. Note them, check them honestly, and set them aside — but be conservative about this pile. Authors put things in it that belong in the first pile, and that mistake earns a second rejection.

If a criticism appears in two independent reviews, it belongs in the first pile regardless of what you think of it. Two people finding the same problem means the manuscript caused it, even if both are technically wrong — something in the text created the misreading.

The shape of the finished sort is itself the decision. A set in which almost every comment lands in the venue-specific pile is describing a fit failure, and the paper can move this week. A set with three or four comments in the first pile is describing work, and the honest schedule is weeks or months. A set in which most comments land in the wrong pile has been sorted by an author who has not yet waited the week.

This sorting method assumes a standard post-submission review of a completed study. It works differently for a Registered Report: at Stage 1 review, reviewers evaluate the protocol before any data exist, so a rejection means the design itself did not clear in-principle acceptance — there is no completed result to triage into piles, only a protocol to revise or abandon before data collection starts.

Common questions about sorting reviewer comments

Is a harsh review always right?

No. Tone and correctness are independent judgments. A reviewer who writes with irritation can still be naming a real flaw in your data, and a courteously worded review can still be wrong. Sort by what the comment names — your data, design or wording versus the venue’s threshold — not by how it is phrased; harshness carries no information about which pile a comment belongs in.

How do I know if a reviewer criticism is fatal?

Ask whether the central claim survives if the criticism is correct. If it does not, and you cannot address it, the claim has to change — narrow it or drop it. If the claim does survive, the criticism concerns rigour of presentation rather than validity, and belongs in the first pile only if a second reviewer raised it too.

Two reviewers contradicted each other. Which do I follow?

If you are resubmitting elsewhere, neither is binding. Use your judgement, and note that a contradiction often means the manuscript was ambiguous enough to support both readings — itself a fixable problem. A frequent special case is a statistical reviewer and a domain reviewer disagreeing about the same result for different reasons; both objections usually need answering, not just one.

I got three pages of criticism from one reviewer and two sentences from the other — does that mean the harsher reviewer is the one who’s right?

No — length measures effort, not validity. A two-sentence comment that names your control condition or your unit of analysis can outweigh three pages of stylistic objections, because it points at something falsifiable in the manuscript. Read each comment for what it names, not how much space it took, before assigning it to a pile.

How to tell a recurring objection from a venue-specific one

Whether an objection is a recurring one or a venue-specific one depends on what it names: your data, design, figure or wording point at the manuscript and travel with it to the next journal; the venue’s readership, threshold or scope point at the journal and stay behind.

Read the two side by side. “The generality claimed in the title is not supported by a single cell line” names your data; it recurs. “The advance over the work in reference 12 is incremental for a journal of this scope” names the venue, and belongs with novelty and incrementalism objections rather than in the revision list. “This study falls outside the range of topics we cover” is an out-of-scope objection and carries no information about the science at all.

Three further signals are worth reading deliberately. A criticism phrased as a question — “were the cultures independently derived?” — is usually a presentation failure rather than a design failure: the answer is in the paper, the reviewer could not find it, and the next reviewer will not find it either. That specific question is often really asking about pseudoreplication — the problem, named by Hurlbert in 1984, of treating technical replicates or repeated measurements on one biological unit as if they were independent units of analysis; see reviewer says n is not independent. It recurs because it is a property of the analysis, not of the venue. A demand for a control almost always recurs, because a control is a property of the experiment and not of the audience; a reviewer who asks for one is describing the study, not the readership. And an objection that both reviewers raise in different vocabulary is one objection, not two, and it is the one to fix first.

What the decision letter tells you that the reviews do not

The decision letter is the shortest document in the set and the most decisive, because the editor has already done the triage you are about to repeat. Read it for exactly three things: which objection the editor restates in their own words, whether the wording leaves a door open, and whether a transfer was offered.

Whatever the editor restates is binding. Reviewers raise a dozen points and editors quote one or two; the quoted ones are the reasons the paper was declined, and the remainder is advice. A letter that reproduces the reports without adding a sentence of its own is telling you the decision rested on the reviews as a whole.

The wording of the decline separates two very different outcomes that arrive in similar envelopes. “We are unable to offer publication” is final. “We would be willing to consider a new submission” — often labelled reject and resubmit — is an invitation, and it is not a rejection in the ordinary sense: the paper returns to the same editor, usually to the same reviewers, and the work in front of you is revision rather than relocation. Where a letter carries that wording, ask the editorial office two questions before starting: whether the invitation has a deadline, and whether the original reviewers will be used. Both answers change the schedule, and neither is usually stated in the letter.

Deciding what to do

Deciding what to do next follows directly from which pile the objections landed in: a text or reanalysis fix, a fix that requires new experiments, a claim that has to narrow, or — rarely — a central claim that does not survive at all.

Fixable, and the fix is text or reanalysis. Do it, then resubmit to a comparable journal. Most rejections are here. The category is larger than authors expect, because “claims exceeding evidence” is a text problem with a text remedy — the sentences change and the experiments do not. The trap is partial revision: a reanalysis that changes a number changes every sentence that quotes it, and a claim left standing after its supporting analysis moved is the most reliable way to draw the same objection at the next journal.

Fixable, and the fix is experiments. Decide whether the experiment is worth it against what the paper becomes with it. Sometimes the honest answer is to publish the smaller claim now. A usable test: write out the sentence the new experiment would let you put in the abstract, then ask whether that sentence is the one the paper needs. If it only converts “consistent with” into “supports”, the months are usually better spent elsewhere.

Not fixable, claims must narrow. Narrow them, and choose a venue matched to the smaller claim. This is a legitimate and common outcome. Narrowing is a specific operation rather than an attitude: a mechanistic title becomes an associational one, a general population becomes the studied population, and a claim about a molecular target becomes a claim about a phenotype. See reviewer says the mechanism is not shown for the commonest version and the wording that survives it.

Not fixable, and the central claim does not survive. Rare but real. The result may still be publishable as a negative or preliminary finding, and it is better to discover this from a reviewer than after publication. What makes such a paper publishable is reporting it as what it is — a well-powered null, a failure to replicate, a method that did not work — rather than dressing the surviving fragment as the original claim. A reviewer asking for replication of a finding that did not hold is asking the same question in a politer form.

When the fix is an experiment you cannot run

When the fix a reviewer wants is an experiment you can no longer run, four moves substitute for it: narrow the claim, substitute an orthogonal measurement, state the gap as a bounded limitation, or disclose the constraint in the cover letter. Arguing that the experiment was unnecessary is not among them, and reviewers read that argument as evasion every time. The cohort is closed, the biobank material is exhausted, the ethics approval has expired, the antibody lot is discontinued, or the person who ran the assay finished their contract two years ago. All of these are ordinary, and all of them have the same four moves.

Narrow the claim to what the existing data support. This move always works, because it needs nothing you do not already have. It is also the move authors reach for last.

Substitute an orthogonal measurement on material you still hold. A second, methodologically independent line of evidence for the same conclusion answers the objection without reproducing the experiment — see orthogonal validation for what counts as independent and what merely looks it.

State the gap as a bounded limitation, naming the experiment. Write which experiment would settle the question, what each possible outcome would show, and why it could not be run here. A limitations section that names the missing experiment reads as command of the evidence; one that says the results “should be interpreted with caution” reads as an admission with no analysis attached.

Say so plainly in the cover letter. Where a reviewer at the previous journal demanded something unobtainable, one sentence in the cover letter stating the constraint and the substitute pre-empts the same demand arriving again. The nearest alternative offered voluntarily is received very differently from the same alternative offered after a second refusal.

The move to avoid is arguing that the requested experiment lies beyond the scope of the study. Occasionally true, almost always heard as a refusal, and it converts a methodological conversation into a dispute about whose judgement governs — which is the conversation authors lose.

Questions about revising and resubmitting

Should I fix the paper before resubmitting elsewhere?

Yes, for any criticism that would recur — reviewers at other journals are drawn from the same pool and raise the same objections, usually with less patience the second time. Venue-specific comments do not need fixing before you move; fixing them anyway rarely hurts, but it is not what the rejection was about.

How long should I wait before resubmitting?

Long enough to make the revisions properly — the week the sorting exercise takes is a floor, not a target. Same-day resubmission with no changes is the most common avoidable error after a rejection, and a paper that changed nothing meets the same reviewers’ objections at the next venue too.

Is it worth asking the editor for more feedback?

Occasionally, and politely. Editors sometimes explain what tipped a mixed set of reviews toward rejection, since that is exactly the judgement call you are trying to reconstruct. Keep the message short, ask rather than argue, and do not treat a non-answer as evidence the decision was arbitrary.

Reviewer wants an experiment I can’t run anymore — is my paper dead?

Not automatically. Four moves substitute for a remedy you no longer have: narrow the claim to what the existing data support, substitute an orthogonal measurement on material you still hold, state the gap as a bounded limitation naming the missing experiment, and say so in the cover letter before anyone asks again.

My reviewer said my study is underpowered but didn’t run a power calculation — do I have to trust that?

Not blindly, but don’t dismiss it either. A reviewer can raise power without a formal calculation if the effect claimed is implausibly large for the n reported, or if similar published designs needed far more subjects. Ask for the specific comparison; if none is offered, a post-hoc power argument from your own data is weak evidence either way, and the honest fix is a prospective calculation for the revision.

Choosing the next journal

Match the venue to the paper as revised, not as originally conceived. If the claims narrowed, the target should move with them.

Read recent contents rather than the aims and scope page, and match on shape — descriptive versus mechanistic, basic versus clinical — as well as topic. Most avoidable rejections are fit failures the author could have detected in twenty minutes.

Shape matching is more specific than it sounds. Read the last several issues and check four things: whether the journal publishes single-system studies or expects two independent systems, whether its papers carry mechanism or stop at association, whether its typical study is larger than yours by an order of magnitude, and whether anything it published in the past year would cite your paper. A journal that does not publish the study type you are submitting will not start with yours, and that is visible from a table of contents in less time than reformatting the references takes. Journal selection covers the fit assessment in full, and desk rejected without review covers the same mismatch caught before review rather than after.

Aiming one tier down is the reflex, and it is not always right. A paper rejected on significance and unchanged in substance meets the same significance question one tier down, only later. A paper rejected on a methodological gap meets a harder version of that gap at a journal with a dedicated statistical reviewer. Tier is the wrong axis; the match between the claim and the audience is the right one.

Transfers, cascades and portable review

If the rejecting journal offered a transfer to a sister title, consider it seriously: the reviews travel with the paper and the next round is usually much faster. The general practice is called cascading peer review — the reports written for the first journal are forwarded, with the author’s agreement, to a second journal in the same portfolio, which decides with the reviews in hand instead of commissioning new ones.

Three questions decide whether to accept one. Is the receiving title a journal you would have chosen independently, or only the next one along the same corridor? Does the receiving editor make a fresh decision, or is the transfer an acceptance in all but name? And may you revise before the transfer completes — which most schemes permit and most authors never ask about, because transferring the unrevised manuscript hands the new editor the same objections and none of your answers.

Journal-independent review is the other route to a portable review set. Review Commons, operated jointly by ASAPbio and EMBO, reviews a preprint before any journal sees it and then carries that review to affiliate journals including eLife, PLOS Biology, The EMBO Journal and the Journal of Cell Biology. What both routes have in common is that a review set is an asset with a shelf life: it stops being portable the moment the manuscript changes enough that the reports no longer describe it.

One boundary is worth knowing. Reviewer reports are not yours to publish. The ICMJE Recommendations state that “Editors should not publish or publicize peer reviewers’ comments without permission of the reviewer and author.” Sending a report to a second editor as part of your own submission moves confidential material between parties already entitled to see it; posting it does not.

What to tell the next journal

Disclosure of a previous rejection to the next journal is optional: nothing in the ICMJE Recommendations requires it, and most authors say nothing. Where the previous reviews were substantive and you addressed them, some editors welcome being told and it can shorten review.

The obligation genuinely does not exist. The ICMJE Recommendations contain no clause requiring an author to disclose a prior rejection, and no journal learns of one from any shared record — ICMJE describes submitted manuscripts as “authors’ private, confidential property”, the same principle that keeps a rejected submission invisible to everyone but the journal that handled it. What ICMJE does forbid is having the paper under consideration in two places at once: “Authors should not submit the same manuscript, in the same or different languages, simultaneously to more than one journal.” An appeal in progress counts as consideration, which is why appealing and submitting elsewhere are alternatives rather than a hedge.

Where you do disclose, disclose usefully. A cover letter saying the paper was reviewed at another journal, enclosing the previous reports and a point-by-point account of what changed, gives an editor something to act on; a sentence saying the paper was rejected elsewhere gives them only a prior. A response-to-reviewers document written for reviewers who will never read it remains the clearest way to show an editor that the objections were answered rather than waited out.

Never conceal a rejection that raised an integrity concern.

Questions about transfers and disclosure

Can I submit to another journal while I decide what to do?

Not to two at once. The ICMJE Recommendations state that “Authors should not submit the same manuscript, in the same or different languages, simultaneously to more than one journal”, and an appeal keeps the paper under consideration at the original venue. Choose one route and finish it.

Should I accept the journal’s offer to transfer my paper to a sister title?

Accept it if the receiving journal is one you would have chosen anyway, and revise before the transfer completes if the scheme allows it. The reviews travel with the paper, which usually makes the next round much faster, but transferring an unrevised manuscript sends the new editor the objections without your answers.

Do I have to tell the new journal my paper was rejected somewhere else?

No obligation exists — the ICMJE Recommendations describe a submitted manuscript as the author’s private, confidential property, and no journal learns of a rejection elsewhere from any shared record. Disclosing anyway can help when the previous review was substantive: enclosing the prior reports with a point-by-point account of what changed gives an editor something to act on that a bare mention does not.

What reviewers say, and which pile it belongs in

Reviewers never write “this objection would recur anywhere”. They write the specific version, and the sorting rule is legible in the wording.

The rows that decide papers are the first and the last. A conclusions-versus-data comment appears in some form in most substantive review sets, and it is the one authors most often put in the wrong pile, because it feels like a matter of emphasis and is in fact a matter of evidence. Where you disagree with a comment, the safe procedure is to fix the ambiguity that produced it and leave the substance alone — methods and design objections sets out what that family expects in return.

The “effect, while significant, is small” row has a specialist answer too. A design that states its smallest effect size of interest before the data are collected, and tests against that bound rather than only against zero (equivalence testing, of which the two one-sided tests procedure is the common form), forecloses the objection outright: the reviewer can check the stated bound against the observed effect instead of substituting their own impression of what counts as small. A design that never named a bound has nothing to point the reviewer to, and “small” stays an argument about intuition.

Before resubmitting

Before resubmitting, two checks matter more than any other pass, because both test whether the objection that sank the paper last time would still apply. The overclaim check catches claims that did not move when the analysis did — the most common reason a revised paper draws the same objection twice. The study section lens tests whether the significance argument that failed at the last venue would fail again, which is the question that should determine where you send it.

Three shorter checks belong beside them. Re-read the abstract on its own and ask whether it states the narrowed claim rather than the original one; the abstract is drafted first and revised last, and it is where superseded claims survive. Reconcile every number that appears in more than one place — abstract, results, table, figure legend — because a reanalysis rarely propagates cleanly. And read your own first pile once more, as a stranger would, checking that each comment has an answer in the manuscript rather than in your intentions.

More in this family: why papers get rejected, how to write a response to reviewers.

PerfectPaper reads a rejected manuscript against the objections a fresh set of reviewers would raise, and reports which of them the revision has not yet answered. The review is expert-led and AI-assisted: it produces reviewer-shaped comments pinned to the passage that provoked them, so an author can separate the recurring objection from the venue-specific one before the paper moves.

Review my manuscript